Marker Therapeutics, Inc. MRKR
1.09 USD -0.23 (-17.42%)
Regular-session close
1.01 -0.08 -7.17%
After hours · Nov 20, 7:55 PM ET
1.09 Day range 1.45
0.81 52-week range 2.46
- YTD
- -26.85%
- 1 year
- +10.10%
MRKR revenue history
Revenue is income from the company’s ordinary business activities.
3,546,669 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 3,546,669 | -3,044,411 | -46.19% |
| FY 2024 | 2024-12-31 | 6,591,080 | 3,279,947 | 99.06% |
| FY 2023 | 2023-12-31 | 3,311,133 | -202,411 | -5.76% |
| FY 2022 | 2022-12-31 | 3,513,544 | 2,271,834 | 182.96% |
| FY 2021 | 2021-12-31 | 1,241,710 | 774,925 | 166.01% |
| FY 2020 | 2020-12-31 | 466,785 | 253,591 | 118.95% |
| FY 2019 | 2019-12-31 | 213,194 | 7,200 | 3.50% |
| FY 2018 | 2018-12-31 | 205,994 | 22,930 | 12.53% |
| FY 2017 | 2017-12-31 | 183,064 | 183,064 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | 0 | Not meaningful |
| FY 2012 | 2012-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-19T07:00:40.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
